Financing

Visa Stock Chart Suggests Bearish Momentum Ahead Of Q2 Earnings
Several Companies Under Elon Musk Billed Each Other Approximately $9 Million In Expenses, Raising Serious Questions About Corporate Governance
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
Several Companies Under Elon Musk Billed Each Other Approximately $9 Million In Expenses, Raising Serious Questions About Corporate Governance
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
Eramet's $800M Lithium Investment A Vote Of Confidence For Argentinian Economic Turnaround
What's The Net Worth Of These 4/20 Underdogs? Mid-Tier Cannabis Retailers & Cultivators Under The Spotlight

Financing Recent News

Small Group Of Hedge Funds Wields Dominance In US Treasury Market: 'A Concentration Of Vulnerability Has Built Up,' IMF Warns
The IMF is concerned about highly-leveraged hedge funds dominating the U.S. Treasury futures market, which could lead to systemic threats and instability in the global economy.
Carrier Global Invests In Strategic Thermal Labs For Data Center Cooling Solutions
Carrier Global teams up with Strategic Thermal Labs (STL) for liquid cooling innovation in data centers. Explore how this investment aligns with Carrier's commitment to cutting-edge climate solutions.
EXCLUSIVE: Focus On Selling Numbers, Not Dreams, That's What Makes Cannabis A Good Investment
"Not trying to always be the next unicorn is okay… it's actually great." That's according to Morgan Paxhia, a co-founder and managing director at Poseidon Investment Management. He told those gathered at the Benzinga Cannabis Capital Conference in Florida on Wednesday that selling a cannabis business and then building a new one from scratch is not a bad idea. "We need to see good investments being made, entrepreneurs being realistic about the valuations and building good companies… and not being afraid to hit the bit," Paxhia said. That, actually is a great way to attract investors' attention, he added. Paxhia joined three other experts, John Darwin, a managing partner of Luminous Capital, Brett Finkelstein, a managing partner of Skyvest Partners LP and Meris Kott, CEO of Shiny Health & Wellness Corp., on the stage at The Diplomat Beach Resort in Hollywood in a panel discussion moderated by Tom Zuber, a founder and the managing partner of Zuber Lawler, on what makes a company investable in the cannabis industry.
Why Children's Place Shares Are Skyrocketing Today
Children's Place Inc. experiences a significant uptick in shares following the announcement of a new financing agreement with majority shareholder Mithaq Capital SPC. The $90 million unsecured and subordinated term loan, expected to be funded by April 19, 2024, promises enhanced liquidity and favorable terms compared to previous arrangements.
It All Started With Cannabis: How This Innovative Manufacturing Software Firm Is Solving 'Real' Problem For Its Customers
Elevated Signals recently reported securing CA$7.9 million in Series A funding. The investment led by Yaletown Partners, with participation from Third Kind Venture Capital, WGD Capital, Colin Harris, Raiven Capital, and Pareto Holdings is slated to help the company expand and diversify in terms of the industries it serves. "Elevated Signals is solving a real problem for its customers and is aligned with larger trends in the market," Hans Knapp, general Partner and co-founder at Yaletown Partners, said recently.
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement. Acquisition expected mid-2024.
This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape
PharmaCielo revealed its plans to acquire cannabis operations in Thailand.On Wednesday, the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., said it has signed a binding letter of intent to enter a proposed transaction to acquire 100% of the issued and outstanding shares of Siam Ventures Corporation in exchange for common shares of PharmaCielo equaling to CA$3 million ($2.2 million).PharmaCielo also revealed it's undertaking a non-brokered private placement of 9,090,909 units at CA$0.2 per unit. Under the deal, the sum will be payable on closing by way of the issuance of 13,636,363 PharmaCielo Shares to the Siam Ventures' shareholders on a pro-rata basis.
Cannabis REIT Chicago Atlantic Closes $20M Facility With Massachusetts Weed Co. That Plans To Expand In These Key Markets
Massachusetts-based integrated cannabis operator Nova Farms has received a $20 million loan facility from Chicago Atlantic Real Estate Finance. Nova Farms manages a Massachusetts cultivation farm, seven retail brands, and five full-service dispensaries across the Bay State, Maine, and New Jersey. It was among the first businesses to secure licenses in Massachusetts upon the state's legalization of recreational cannabis back in 2016. Chicago Atlantic's capital investment is expected to back Nova Farms' efforts to expand its footprint of dispensaries in key states, namely New Jersey and Connecticut.
Acrivon Therapeutics Stock Is Soaring Tuesday: What's Going On?
Acrivon Therapeutics has entered into a securities purchase agreement to issue and sell 8.235 million shares of its common stock at a price of $8.50 per share, as well as pre-funded warrants to purchase up to 7.06 million shares through a private investment in public equity (PIPE) financing.
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, and future plans. Stay updated on Protara Therapeutics' advancements in cancer therapy and FDA alignment for Choline Chloride.
Flora Growth's Stock Trading Higher On Pricing $3.2M Public Offering Of Common Shares
Flora Growth Corp. announced on Thursday the pricing of its underwritten public offering of 1.7 million common shares for aggregate gross proceeds of roughly $3.23 million. Clifford Starke, the company's CEO, and an existing investor have agreed to purchase, and have been allocated by Aegis Capital Corp., Common Shares in the offering. Flora said it will use the net proceeds from the transaction that is expected to close on or about Monday, April 8 for general corporate and working capital needs. The move came on the heels of the company's latest move to further cement its global footprint via acquisition in Germany.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers